Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioCardia

1.51
+0.170012.69%
Post-market: 1.48-0.0300-1.99%19:56 EDT
Volume:841.67K
Turnover:1.24M
Market Cap:16.02M
PE:-0.73
High:1.57
Open:1.34
Low:1.33
Close:1.34
52wk High:3.20
52wk Low:1.00
Shares:10.61M
Float Shares:4.05M
Volume Ratio:3.33
T/O Rate:20.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0546
EPS(LYR):-2.8960
ROE:-737.89%
ROA:-222.28%
PB:-8.49
PE(LYR):-0.52

Loading ...

BioCardia Inc - Reduced Angina Episodes at Six-Month Primary Follow-up

THOMSON REUTERS
·
Sep 18

BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up

GlobeNewswire
·
Sep 18

BioCardia files to sell 2.8M shares of common stock, warrants

TIPRANKS
·
Sep 16

BioCardia Inc Files for Offering of up to 2.8 Mln Shares of Common Stock Together With up to 2.8 Mln Common Warrants

THOMSON REUTERS
·
Sep 16

BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025

GlobeNewswire
·
Sep 04

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Aug 25

BioCardia and CART-Tech Partner to Develop Heart3D™ Fusion Imaging for Cardiology

Reuters
·
Aug 13

BioCardia and Cart-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3d™ Fusion Imaging for Interventional Cardiology

THOMSON REUTERS
·
Aug 13

BioCardia Inc. CEO Peter Altman Reports Acquisition of Common Shares

Reuters
·
Aug 12

BioCardia Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11

BioCardia Q2 EPS $(0.40) Beats $(0.50) Estimate

Benzinga
·
Aug 11

BioCardia Inc. Secures Patent for Innovative Catheter System Enhancing Heart Treatment Delivery

Reuters
·
Aug 11

BioCardia, Inc. Q2 Net Income USD -2.049 Million

THOMSON REUTERS
·
Aug 11

BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results

GlobeNewswire
·
Aug 11

BioCardia Inc expected to post a loss of 50 cents a share - Earnings Preview

Reuters
·
Aug 08

BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025

GlobeNewswire
·
Aug 07

BRIEF-BioCardia Provides Update On Timing Of Regulatory Activities Seeking FDA Approval And Japan Pmda Approval For Cardiamp® Cell Therapy For Heart Failure And Helix™ Transendocardial Delivery Catheter

Reuters
·
Aug 04

BioCardia Inc - Helix FDA Approval Application Planned for Q3 2025

THOMSON REUTERS
·
Aug 04

BioCardia Inc - Cardiamp Clinical Consultation With Japan Pmda Expected Q4 2025

THOMSON REUTERS
·
Aug 04

BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan Pmda Approval for Cardiamp® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter

THOMSON REUTERS
·
Aug 04